Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs GetRelief Rx

Boston Medical Group
Graded #113

Higher grade

vs+11.300000000000004
GetRelief Rx
Graded #365

Lower grade

The verdict

Boston Medical Group takes it — 69.9/100 to 58.6/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +44
86
42
Dose & formulationGetRelief Rx +26
52
78
Clinical oversightBoston Medical Group +19
89
70
Labs & monitoringBoston Medical Group +1
53
52
FulfillmentBoston Medical Group +7
65
58
Contract termsBoston Medical Group +8
55
47
Boston Medical Group · left barGetRelief Rx · right bar

The numbers

MetricBoston Medical GroupGetRelief Rx
WeighScore69.9/10058.6/100
GradeCC
Scorecard rank#113#365
Semaglutide$66/mo (starting dose, compounded)$269/mo (9 mg dose, compounded oral)
TirzepatideNot disclosed$179/mo (16 mg dose, compounded oral)
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
GetRelief Rx

Graded #365 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard